Skip to main content

Table 1 Baseline characteristics of the participants

From: Effect of intermittent versus continuous calorie restriction on body weight and cardiometabolic risk markers in subjects with overweight or obesity and mild-to-moderate hypertriglyceridemia: a randomized trial

Variable

CCR (n = 44)

ICR (n = 44)

P-value

Age (years)

45.2 ± 11.7

44.0 ± 8.6

0.60

Sex (number of men)

15

10

0.34

Weight (kg)

90.1 ± 19.3

83.9 ± 13.7

0.09

BMI (kg/m2)

32.4 ± 4.6

31.6 ± 3.9

0.38

 Overweight (n)

17

17

1.0

 Obese (n)

27

27

Fat mass (%)

35.9 ± 5.8

37.5 ± 4.6

0.14

Fat-free mass (%)

63.6 ± 5.4

63.0 ± 5.9

0.60

Waist circumference (cm)

104.7 ± 11.0

100.6 ± 9.8

0.067

History of hypertension (n)

5

6

0.52

History of diabetes mellitus (n)

7

5

0.51

Medications

 Statins (n)

8

11

0.60

 ACE-I (n)

3

2

0.63

 ARB (n)

2

4

0.76

Plasma creatinine (mg/dL)

1.0 ± 0.1

1.0 ± 0.2

0.60

TG (mg/dL)

165.0 (126)

180.5 (115)

0.84

Cholesterol (mg/dL)

190.1 ± 38.1

178.6 ± 30.3

0.12

LDL-C (mg/dL)

107.7 ± 29.0

98.4 ± 28.5

0.13

HDL-C (mg/dL)

42.1 ± 10.6

39.1 ± 7.7

0.13

FBS (mg/dL)

89.5 (16)

88.0 (26)

0.18

Insulin (μIU/mL)

22.0 ± 9.7

18.2 ± 8.1

0.046

HOMA-IR

3.7 (3)

3.5 (3)

0.37

  1. Data presented as mean ± SD, median (interquartile range) or percentages for dichotomous measures
  2. ACE-I Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker, BMI body mass index, CCR Continous calorie restriction diet, HDL-C high-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment of insulin resistance, ICR Intermittent calorie restriction diet, LDL-C low-density lipoprotein cholesterol, TG triglycerides